UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054934
Receipt number R000062719
Scientific Title Development of a real-world database for cancer patients in Japan
Date of disclosure of the study information 2024/07/11
Last modified on 2025/10/07 17:16:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a real-world database for cancer patients in Japan

Acronym

Development of a real-world database for cancer patients in Japan

Scientific Title

Development of a real-world database for cancer patients in Japan

Scientific Title:Acronym

Development of a real-world database for cancer patients in Japan

Region

Japan


Condition

Condition

- Breast cancer
- Thoracic malignancy (non-small cell lung cancer, small cell lung cancer, etc.)
- Gastrointestinal cancer (pancreatic cancer, liver cancer)

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Pneumology
Endocrinology and Metabolism Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Chest surgery Breast surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To curate high-quality oncology real-world data based on existing and future medical records at the Nagoya University Hospital, and to conduct research utilizing this RWD for the furtherance of research and medical care for cancer in Japan

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Real-world overall survival, time-to-next-treatment, progression-free survival, time-to-treatment-discontinuation etc.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following criteria will be included in this study:

1. Patients who received care at Nagoya University Hospital between January 1, 2011 and December 31, 2028
2. Patients with a confirmed diagnosis of any of the following tumor types:
- Breast cancer
- Thoracic malignancy (non-small cell lung cancer, small cell lung cancer,etc)
- Gastrointestinal cancer (pancreatic cancer, liver cancer)
3. Patients aged 18 and above
4. Patient(or a legal surrogate) has either confirmed willingness to participate in the study through one of the following methods, or has not expressed a decline to participate.
- Written informed consent has been obtained using study-specific explanatory and consent documents.
- For eligible patients who visited the Nagoya University Hospital on or after January 1, 2011, and are already deceased, no objection to participation has been received from the patient's legal surrogate after being provided with an opportunity to decline participation in this study,provided that this does not contradict the explicit wishes expressed by the patient during their lifetime.
Surrogate: Spouse, parents, siblings, children/grandchildren, grandparents, relatives living together with the subject patient, or persons considered to be equivalent to such close relatives (excluding minors).

Key exclusion criteria

None

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Shoichi
Middle name
Last name Maruyama

Organization

Nagoya University Hospital

Division name

Hospital Director

Zip code

466-8560

Address

65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan

TEL

052-741-2111

Email

marus@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Toyone
Middle name
Last name Kikumori

Organization

Nagoya University Hospital

Division name

Breast and Endocrine Surgery Department

Zip code

466-8560

Address

65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan

TEL

052-741-2111

Homepage URL


Email

kikumori@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Hospital

Institute

Department

Personal name



Funding Source

Organization

Flatiron Health K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Flatiron Health K.K.

Name of secondary funder(s)

Nagoya University Hospital


IRB Contact (For public release)

Organization

Institutional Review Board of the Ethics Committee of Nagoya University Hospital

Address

65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan 466-8560

Tel

052-741-2111

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 11 Month 29 Day

Date of IRB

2023 Year 11 Month 29 Day

Anticipated trial start date

2023 Year 12 Month 25 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

NA


Management information

Registered date

2024 Year 07 Month 11 Day

Last modified on

2025 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062719